HomeCompareSKLUY vs PFE

SKLUY vs PFE: Dividend Comparison 2026

SKLUY yields 9.67% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SKLUY wins by $26775.27M in total portfolio value
10 years
SKLUY
SKLUY
● Live price
9.67%
Share price
$29.70
Annual div
$2.87
5Y div CAGR
88.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26775.32M
Annual income
$25,847,201,701.59
Full SKLUY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SKLUY vs PFE

📍 SKLUY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSKLUYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SKLUY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SKLUY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SKLUY
Annual income on $10K today (after 15% tax)
$822.15/yr
After 10yr DRIP, annual income (after tax)
$21,970,121,446.35/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, SKLUY beats the other by $21,970,099,126.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SKLUY + PFE for your $10,000?

SKLUY: 50%PFE: 50%
100% PFE50/50100% SKLUY
Portfolio after 10yr
$13387.69M
Annual income
$12,923,613,980.15/yr
Blended yield
96.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SKLUY
No analyst data
Altman Z
7.0
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SKLUY buys
0
PFE buys
0
No recent congressional trades found for SKLUY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSKLUYPFE
Forward yield9.67%6.13%
Annual dividend / share$2.87$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR88.5%13.2%
Portfolio after 10y$26775.32M$49.6K
Annual income after 10y$25,847,201,701.59$26,258.71
Total dividends collected$26710.83M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SKLUY vs PFE ($10,000, DRIP)

YearSKLUY PortfolioSKLUY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,523$1,823.25$9,153$693.39+$3.4KSKLUY
2$17,422$4,022.44$8,593$849.25+$8.8KSKLUY
3$28,500$9,858.39$8,336$1,066.78+$20.2KSKLUY
4$58,906$28,410.37$8,437$1,384.80+$50.5KSKLUY
5$166,475$103,445.71$9,013$1,875.40+$157.5KSKLUY
6$693,157$515,028.75$10,306$2,680.72+$682.9KSKLUY
7$4,519,505$3,777,827.26$12,820$4,101.38+$4.51MSKLUY
8$48,229,811$43,393,940.30$17,673$6,826.70+$48.21MSKLUY
9$867,401,483$815,795,586.12$27,543$12,591.86+$867.37MSKLUY
10$26,775,321,289$25,847,201,701.59$49,560$26,258.71+$26775.27MSKLUY

SKLUY vs PFE: Complete Analysis 2026

SKLUYStock

Skellerup Holdings Limited designs, manufactures, markets, and distributes engineered products for various specialist industrial and agricultural applications. It operates through Agri and Industrial segments. The company offers food grade dairy rubberware, including milking liners, tubing products, accessories, filters, feeding teats, and other related agricultural products; rubber footwear for application in farm, as well as fire, forestry, and electrical distribution; dairy vacuum pumps; and dairy hygiene and livestock health management products, as well as mastitis prevention and mastitis detection equipment. It also provides sealing and waterproofing products for roofing, plumbing, and civil/underground applications; rubber and plastic products and components, such as pipe seals, diaphragms, washers, gaskets, customized rubber moldings, check valves, O-rings, and other components for use in automotive, industrial, infrastructural pipe, valve, and medical industries; high precision technical products for the automotive, flow control or water management, appliance, and industrial markets; and fabric reinforced diaphragms, and rubber metal seat valves and injector components, as well as injection-moulded and thermoformed engineered plastic products. In addition, the company offers EVA, PE, and various blended foams for marine, sports, leisure, orthotic/prosthetic, and construction applications; foam and soft material products for healthcare, electronics, construction, and comfort applications; and Flexiflo, a live wall system for installation in new and existing chutes, as well as silicone products. It operates primarily in New Zealand, Australia, North America, the United Kingdom, Ireland, rest of Europe, Asia, and internationally. Skellerup Holdings Limited was founded in 1910 and is based in Auckland, New Zealand.

Full SKLUY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SKLUY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SKLUY vs SCHDSKLUY vs JEPISKLUY vs OSKLUY vs KOSKLUY vs MAINSKLUY vs JNJSKLUY vs MRKSKLUY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.